CN Stock MarketDetailed Quotes

300357 Zhejiang Wolwo Bio-Pharmaceutical

Watchlist
  • 25.05
  • +0.34+1.38%
Market Closed Oct 10 15:00 CST
13.12BMarket Cap42.17P/E (TTM)

Zhejiang Wolwo Bio-Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
11.12%429.26M
18.08%216.25M
-5.34%848.19M
-3.77%673.79M
-0.67%386.3M
-7.31%183.14M
10.94%896.02M
12.98%700.18M
11.88%388.9M
20.00%197.59M
Operating revenue
11.12%429.26M
18.08%216.25M
-5.34%848.19M
-3.77%673.79M
-0.67%386.3M
-7.31%183.14M
10.94%896.02M
12.98%700.18M
11.88%388.9M
20.00%197.59M
Other operating revenue
770.36%2.19M
----
554.82%7.44M
----
-55.85%251.51K
----
-68.23%1.14M
----
-40.00%569.7K
----
Total operating cost
15.08%265.41M
19.37%132.39M
5.48%513.94M
5.30%373.88M
9.67%230.62M
2.59%110.91M
11.25%487.24M
13.44%355.06M
9.08%210.29M
13.45%108.11M
Operating cost
11.33%21.69M
8.24%10.42M
-2.64%40.19M
1.14%30.96M
17.93%19.48M
17.47%9.62M
19.86%41.28M
20.07%30.61M
9.55%16.52M
17.75%8.19M
Operating tax surcharges
61.87%3.5M
47.54%1.29M
26.96%5.76M
2.71%3.19M
11.74%2.16M
12.34%876.35K
19.98%4.53M
17.16%3.1M
14.22%1.94M
30.24%780.1K
Operating expense
10.96%163.44M
16.25%80.96M
3.64%323.17M
6.42%242.62M
9.48%147.29M
3.85%69.64M
10.53%311.81M
10.95%227.99M
6.33%134.54M
9.73%67.06M
Administration expense
28.30%33.65M
28.53%16.46M
29.87%62.11M
17.02%40.63M
28.36%26.23M
17.56%12.8M
-7.78%47.82M
-1.49%34.72M
-7.31%20.43M
-5.62%10.89M
Financial expense
-14.08%-16.12M
-13.23%-7.3M
-21.70%-29.48M
-24.46%-22.02M
-19.77%-14.13M
-13.77%-6.45M
-9.37%-24.23M
-5.31%-17.69M
-4.29%-11.8M
-11.77%-5.67M
-Interest expense (Financial expense)
-5.94%619.42K
19.02%319.26K
194.70%1.31M
267.75%915.71K
354.48%658.57K
235.20%268.23K
22.57%443.98K
-9.31%249.01K
-25.62%144.91K
-22.00%80.02K
-Interest Income (Financial expense)
-13.86%-16.9M
-15.15%-7.76M
-24.96%-30.96M
-27.77%-23.03M
-23.74%-14.85M
-16.68%-6.74M
-9.42%-24.77M
-4.99%-18.03M
-3.72%-12M
-11.05%-5.78M
Research and development
19.48%59.25M
25.19%30.56M
5.83%112.2M
2.85%78.49M
1.90%49.59M
-9.08%24.41M
20.58%106.02M
25.31%76.32M
25.60%48.67M
33.25%26.85M
Credit Impairment Loss
-3,268.01%-2.47M
-2,967.77%-1.88M
169.98%903.31K
29.13%-2.95M
109.20%78.07K
109.88%65.63K
19.07%-1.29M
2.75%-4.16M
54.71%-848.48K
13.76%-664.45K
Asset Impairment Loss
----
----
98.94%-472.55K
---472.55K
---472.55K
----
---44.4M
----
----
----
Other net revenue
112.55%8.59M
79.17%4.15M
185.28%10.72M
-97.83%676.75K
-85.79%4.04M
-85.05%2.31M
-154.23%-12.57M
155.46%31.25M
121.35%28.42M
33.46%15.47M
Fair value change income
102.49%30.18K
140.75%400.18K
24.25%-666.94K
-251.92%-1.57M
-272.34%-1.21M
-149.61%-982.13K
-783.37%-880.46K
-73.21%1.04M
-115.66%-325.52K
205.78%1.98M
Invest income
-101.65%-53.11K
-114.74%-363.77K
-46.56%1.91M
-49.43%2.36M
-34.17%3.21M
265.97%2.47M
-44.03%3.58M
193.09%4.67M
186.04%4.88M
-83.28%674.44K
-Including: Investment income associates
46.00%-1.05M
44.73%-434.53K
14.06%-4.25M
-49.08%-3.8M
-65.60%-1.94M
-158.53%-786.13K
-159.16%-4.95M
-1,044.38%-2.55M
---1.17M
---304.08K
Asset deal income
--353.47K
--284.61K
----
----
----
----
---271.92K
---271.92K
---271.92K
---278.78K
Other revenue
341.07%10.73M
649.12%5.71M
-70.54%9.04M
-88.96%3.31M
-90.27%2.43M
-94.46%761.72K
66.12%30.7M
171.22%29.98M
128.65%24.99M
34.89%13.76M
Operating profit
7.97%172.43M
18.06%88.01M
-12.93%344.97M
-20.14%300.59M
-22.86%159.71M
-28.97%74.54M
0.84%396.21M
18.00%376.37M
23.48%207.03M
29.63%104.95M
Add:Non operating Income
-76.22%235.09K
-25.58%117.42K
-35.02%1.78M
-52.61%1.06M
-44.11%988.72K
-87.35%157.78K
340.72%2.74M
-9.93%2.23M
-9.16%1.77M
14,153.97%1.25M
Less:Non operating expense
2,058.31%2.17M
5,587.52%327.4K
306.44%795.74K
113.03%180.72K
27.60%100.62K
-92.70%5.76K
-62.96%195.78K
-81.74%84.83K
-9.97%78.85K
-9.58%78.81K
Total profit
6.16%170.5M
17.54%87.8M
-13.24%345.96M
-20.36%301.46M
-23.06%160.6M
-29.61%74.7M
1.46%398.75M
17.93%378.52M
23.12%208.72M
31.21%106.12M
Less:Income tax cost
47.60%27.88M
80.84%13.88M
-19.98%50.43M
-30.06%41.68M
-41.85%18.89M
-55.25%7.67M
-5.53%63.02M
9.01%59.6M
18.41%32.48M
30.38%17.15M
Net profit
0.64%142.62M
10.29%73.92M
-11.97%295.52M
-18.54%259.78M
-19.59%141.71M
-24.67%67.02M
2.89%335.73M
19.76%318.92M
24.03%176.24M
31.36%88.97M
Net profit from continuing operation
0.64%142.62M
10.29%73.92M
-11.97%295.52M
-18.54%259.78M
-19.59%141.71M
-24.67%67.02M
2.89%335.73M
19.76%318.92M
24.03%176.24M
31.36%88.97M
Less:Minority Profit
4.11%-6.61M
4.81%-3.29M
-12.37%-14.66M
-24.91%-10.37M
-42.43%-6.89M
-25.00%-3.46M
-11.50%-13.05M
-0.00%-8.3M
7.33%-4.84M
-1.43%-2.77M
Net profit of parent company owners
0.42%149.23M
9.55%77.21M
-11.06%310.18M
-17.44%270.15M
-17.93%148.6M
-23.17%70.48M
3.19%348.77M
19.16%327.22M
22.92%181.08M
30.21%91.74M
Earning per share
Basic earning per share
0.42%0.285
9.58%0.1475
-11.06%0.5924
-17.44%0.516
-17.93%0.2838
-23.17%0.1346
3.19%0.6661
19.18%0.625
22.89%0.3458
30.16%0.1752
Diluted earning per share
0.42%0.285
9.58%0.1475
-11.06%0.5924
-17.44%0.516
-17.93%0.2838
-23.17%0.1346
3.19%0.6661
19.18%0.625
22.89%0.3458
30.16%0.1752
Other composite income
56,115.18%5.38M
89,860.06%5.35M
-83.40%4.32K
-72.65%8.11K
-25.55%9.56K
-164.54%-5.96K
-99.90%26.03K
1,087.55%29.66K
483.80%12.84K
-282.10%-2.25K
Other composite income of parent company owners
56,115.18%5.38M
89,860.06%5.35M
-83.40%4.32K
-72.65%8.11K
-25.55%9.56K
-164.54%-5.96K
-99.90%26.03K
1,087.55%29.66K
483.80%12.84K
-282.10%-2.25K
Total composite income
4.43%148M
18.28%79.26M
-11.98%295.53M
-18.55%259.79M
-19.59%141.72M
-24.67%67.01M
-4.68%335.75M
19.77%318.95M
24.04%176.26M
31.36%88.97M
Total composite income of parent company owners
4.03%154.61M
17.15%82.56M
-11.07%310.19M
-17.45%270.16M
-17.94%148.61M
-23.18%70.47M
-4.16%348.8M
19.18%327.25M
22.93%181.09M
30.20%91.73M
Total composite income of minority owners
4.11%-6.61M
4.81%-3.29M
-12.37%-14.66M
-24.91%-10.37M
-42.43%-6.89M
-25.00%-3.46M
-11.50%-13.05M
-0.00%-8.3M
7.33%-4.84M
-1.43%-2.77M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 11.12%429.26M18.08%216.25M-5.34%848.19M-3.77%673.79M-0.67%386.3M-7.31%183.14M10.94%896.02M12.98%700.18M11.88%388.9M20.00%197.59M
Operating revenue 11.12%429.26M18.08%216.25M-5.34%848.19M-3.77%673.79M-0.67%386.3M-7.31%183.14M10.94%896.02M12.98%700.18M11.88%388.9M20.00%197.59M
Other operating revenue 770.36%2.19M----554.82%7.44M-----55.85%251.51K-----68.23%1.14M-----40.00%569.7K----
Total operating cost 15.08%265.41M19.37%132.39M5.48%513.94M5.30%373.88M9.67%230.62M2.59%110.91M11.25%487.24M13.44%355.06M9.08%210.29M13.45%108.11M
Operating cost 11.33%21.69M8.24%10.42M-2.64%40.19M1.14%30.96M17.93%19.48M17.47%9.62M19.86%41.28M20.07%30.61M9.55%16.52M17.75%8.19M
Operating tax surcharges 61.87%3.5M47.54%1.29M26.96%5.76M2.71%3.19M11.74%2.16M12.34%876.35K19.98%4.53M17.16%3.1M14.22%1.94M30.24%780.1K
Operating expense 10.96%163.44M16.25%80.96M3.64%323.17M6.42%242.62M9.48%147.29M3.85%69.64M10.53%311.81M10.95%227.99M6.33%134.54M9.73%67.06M
Administration expense 28.30%33.65M28.53%16.46M29.87%62.11M17.02%40.63M28.36%26.23M17.56%12.8M-7.78%47.82M-1.49%34.72M-7.31%20.43M-5.62%10.89M
Financial expense -14.08%-16.12M-13.23%-7.3M-21.70%-29.48M-24.46%-22.02M-19.77%-14.13M-13.77%-6.45M-9.37%-24.23M-5.31%-17.69M-4.29%-11.8M-11.77%-5.67M
-Interest expense (Financial expense) -5.94%619.42K19.02%319.26K194.70%1.31M267.75%915.71K354.48%658.57K235.20%268.23K22.57%443.98K-9.31%249.01K-25.62%144.91K-22.00%80.02K
-Interest Income (Financial expense) -13.86%-16.9M-15.15%-7.76M-24.96%-30.96M-27.77%-23.03M-23.74%-14.85M-16.68%-6.74M-9.42%-24.77M-4.99%-18.03M-3.72%-12M-11.05%-5.78M
Research and development 19.48%59.25M25.19%30.56M5.83%112.2M2.85%78.49M1.90%49.59M-9.08%24.41M20.58%106.02M25.31%76.32M25.60%48.67M33.25%26.85M
Credit Impairment Loss -3,268.01%-2.47M-2,967.77%-1.88M169.98%903.31K29.13%-2.95M109.20%78.07K109.88%65.63K19.07%-1.29M2.75%-4.16M54.71%-848.48K13.76%-664.45K
Asset Impairment Loss --------98.94%-472.55K---472.55K---472.55K-------44.4M------------
Other net revenue 112.55%8.59M79.17%4.15M185.28%10.72M-97.83%676.75K-85.79%4.04M-85.05%2.31M-154.23%-12.57M155.46%31.25M121.35%28.42M33.46%15.47M
Fair value change income 102.49%30.18K140.75%400.18K24.25%-666.94K-251.92%-1.57M-272.34%-1.21M-149.61%-982.13K-783.37%-880.46K-73.21%1.04M-115.66%-325.52K205.78%1.98M
Invest income -101.65%-53.11K-114.74%-363.77K-46.56%1.91M-49.43%2.36M-34.17%3.21M265.97%2.47M-44.03%3.58M193.09%4.67M186.04%4.88M-83.28%674.44K
-Including: Investment income associates 46.00%-1.05M44.73%-434.53K14.06%-4.25M-49.08%-3.8M-65.60%-1.94M-158.53%-786.13K-159.16%-4.95M-1,044.38%-2.55M---1.17M---304.08K
Asset deal income --353.47K--284.61K-------------------271.92K---271.92K---271.92K---278.78K
Other revenue 341.07%10.73M649.12%5.71M-70.54%9.04M-88.96%3.31M-90.27%2.43M-94.46%761.72K66.12%30.7M171.22%29.98M128.65%24.99M34.89%13.76M
Operating profit 7.97%172.43M18.06%88.01M-12.93%344.97M-20.14%300.59M-22.86%159.71M-28.97%74.54M0.84%396.21M18.00%376.37M23.48%207.03M29.63%104.95M
Add:Non operating Income -76.22%235.09K-25.58%117.42K-35.02%1.78M-52.61%1.06M-44.11%988.72K-87.35%157.78K340.72%2.74M-9.93%2.23M-9.16%1.77M14,153.97%1.25M
Less:Non operating expense 2,058.31%2.17M5,587.52%327.4K306.44%795.74K113.03%180.72K27.60%100.62K-92.70%5.76K-62.96%195.78K-81.74%84.83K-9.97%78.85K-9.58%78.81K
Total profit 6.16%170.5M17.54%87.8M-13.24%345.96M-20.36%301.46M-23.06%160.6M-29.61%74.7M1.46%398.75M17.93%378.52M23.12%208.72M31.21%106.12M
Less:Income tax cost 47.60%27.88M80.84%13.88M-19.98%50.43M-30.06%41.68M-41.85%18.89M-55.25%7.67M-5.53%63.02M9.01%59.6M18.41%32.48M30.38%17.15M
Net profit 0.64%142.62M10.29%73.92M-11.97%295.52M-18.54%259.78M-19.59%141.71M-24.67%67.02M2.89%335.73M19.76%318.92M24.03%176.24M31.36%88.97M
Net profit from continuing operation 0.64%142.62M10.29%73.92M-11.97%295.52M-18.54%259.78M-19.59%141.71M-24.67%67.02M2.89%335.73M19.76%318.92M24.03%176.24M31.36%88.97M
Less:Minority Profit 4.11%-6.61M4.81%-3.29M-12.37%-14.66M-24.91%-10.37M-42.43%-6.89M-25.00%-3.46M-11.50%-13.05M-0.00%-8.3M7.33%-4.84M-1.43%-2.77M
Net profit of parent company owners 0.42%149.23M9.55%77.21M-11.06%310.18M-17.44%270.15M-17.93%148.6M-23.17%70.48M3.19%348.77M19.16%327.22M22.92%181.08M30.21%91.74M
Earning per share
Basic earning per share 0.42%0.2859.58%0.1475-11.06%0.5924-17.44%0.516-17.93%0.2838-23.17%0.13463.19%0.666119.18%0.62522.89%0.345830.16%0.1752
Diluted earning per share 0.42%0.2859.58%0.1475-11.06%0.5924-17.44%0.516-17.93%0.2838-23.17%0.13463.19%0.666119.18%0.62522.89%0.345830.16%0.1752
Other composite income 56,115.18%5.38M89,860.06%5.35M-83.40%4.32K-72.65%8.11K-25.55%9.56K-164.54%-5.96K-99.90%26.03K1,087.55%29.66K483.80%12.84K-282.10%-2.25K
Other composite income of parent company owners 56,115.18%5.38M89,860.06%5.35M-83.40%4.32K-72.65%8.11K-25.55%9.56K-164.54%-5.96K-99.90%26.03K1,087.55%29.66K483.80%12.84K-282.10%-2.25K
Total composite income 4.43%148M18.28%79.26M-11.98%295.53M-18.55%259.79M-19.59%141.72M-24.67%67.01M-4.68%335.75M19.77%318.95M24.04%176.26M31.36%88.97M
Total composite income of parent company owners 4.03%154.61M17.15%82.56M-11.07%310.19M-17.45%270.16M-17.94%148.61M-23.18%70.47M-4.16%348.8M19.18%327.25M22.93%181.09M30.20%91.73M
Total composite income of minority owners 4.11%-6.61M4.81%-3.29M-12.37%-14.66M-24.91%-10.37M-42.43%-6.89M-25.00%-3.46M-11.50%-13.05M-0.00%-8.3M7.33%-4.84M-1.43%-2.77M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data